The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

An expert discussed the rise of “Brotox” and what this means for practitioners as the proportion of men seeking cosmetic ...

Women who reported snoring or having poor diet quality during their first trimester were more likely to develop a ...

Reducing glucocorticoid use in the treatment of giant cell arteritis and polymyalgia rheumatica — due to the steroid’s host ...

Permanent life insurance shares notable characteristics with an asset class many physicians own — real estate — particularly ...

In Nepal, Thailand and Singapore, an individualized short antibiotic course vs. usual care was estimated to be cost effective ...

Specific enterotypes of the gut microbiota in infants aged 1 month may have an impact on the likelihood for food ...

Families, physicians and other stakeholders will be in Washington, D.C., to meet with legislators and advocate for change on ...

Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy ...

In this video, Jennifer A. Woyach, MD, discusses two abstracts from ASH Annual Meeting and Exhibition that evaluated the use of immune therapies to treat chronic lymphocytic leukemia.

The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...

In this video, Tanya Dorff, MD discusses the greatest unmet needs in the treatment of castration-resistant prostate cancer.